Navigation Links
Vision Pharma Is Granted Motion for Judgment
Date:6/4/2009

WALL, N.J., June 4 /PRNewswire/ -- On April 13, 2009, the Trademark Trial and Appeal Board of the U.S. Patent and Trademark Office granted Vision Pharma, LLC's ("Vision Pharma") motion for judgment on the pleadings and ruled that Vision Pharma's VISRX mark is not confusingly similar to Cornerstone Therapeutics, Inc.'s (Nasdaq: CRTX) ("Cornerstone") ALLERX mark.

In response to Vision Pharma's pending trademark application for the mark VISRX, Cornerstone Biopharma, Inc. initiated an opposition proceeding on the basis that Vision Pharma's VISRX mark is likely to cause confusion with Cornerstone's ALLERX mark. In response, Vision Pharma denied the allegations and asserted counterclaims to cancel Cornerstone's registrations for the ALLERX mark. On April 13, 2009, the Trademark Trial and Appeal Board entered an order ruling that Vision Pharma's VISRX mark is not likely to cause confusion with Cornerstone's ALLERX mark. Sander Busman, President & CEO of Vision Pharma said "We are very pleased with the result."

Vision Pharma and Cornerstone Biopharma, Inc. also are involved in patent litigation pending in the U.S. District Court for the Eastern District of North Carolina. The case is stayed while the patent-in-suit is being reexamined by the U.S. Patent and Trademark Office.

About Vision Pharma

Vision Pharma, a rapidly growing generic pharmaceutical company, specializes in niche items with various delivery options and dosage forms. We provide these quality products at competitive prices while improving the lives of those who take our medicines. Our friendly customer service will act promptly to your requests while continuously improving to fulfill your needs. Maintaining additional inventory ensures our ability to provide increased service levels. The pipeline of generic pharmaceuticals that we plan to market continues to grow at a steady rate. Valuable relationships that are built with our customers show our true dedication to each partnering company. You can count on Vision Pharma to be a recognized leader, now and in the future.


'/>"/>
SOURCE Vision Pharma
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Sharing Miracles Television Program to Feature Super Bowl Winner, Hall-of-Famer Mike Ditka
2. LCA-Vision Announces Management Changes
3. Vision impairment costs billions lost in productivity
4. Updegraff Vision Launches Educational Blog/Podcast Site for LASIK and Cataract Patients
5. LCA-Vision Reports on Annual Meeting of Stockholders
6. St. Louis Metro Area Optometrists Partner With Sen. Bond; U.S. House Leaders in Improving Infant Eye and Vision Care
7. Unilens Vision Reports Record Third Quarter Revenue, and Royalty Income
8. Oh Baby! Discovery Healths BABY WEEK Offers the Most Pregnancies, Births and Drama Anywhere on Television
9. National Eyewear Chain Visionworks Opens Two New Stores in Orlando Market
10. Top 10 Tips to Save Your Vision
11. The National Coalition for Osteoporosis and Related Bone Diseases Briefed Congress on Action Plan for a National Vision for Bone Health
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... ... 2016 , ... TopConsumerReviews.com recently awarded their highest five-star rating to Best Buy ... in the United States and Canada wear eyeglasses. Once considered to be a purely ... make a fashion statement. Even celebrities use glasses as a way of creating an ...
(Date:6/26/2016)... ... ... Kasmer, a legally blind and certified personal trainer is helping to develop a weight loss ... plans to fix the two major problems leading the fitness industry today:, ... , They don’t eliminate all the reasons people quit their exercise program ...
(Date:6/25/2016)... California (PRWEB) , ... June 25, 2016 , ... "With ... fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... customizable and all within Final Cut Pro X . Simply select a ProHand ...
(Date:6/25/2016)... Montreal, Canada (PRWEB) , ... June 25, 2016 , ... ... the pursuit of success. In terms of the latter, setting the bar too high ... low, risk more than just slow progress toward their goal. , Research from ...
(Date:6/24/2016)... ... June 24, 2016 , ... The ... in Dallas that it will receive two significant new grants to support its ... PHA marked its 25th anniversary by recognizing patients, medical professionals and scientists for ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016   Pulmatrix, Inc ., ... developing innovative inhaled drugs, announced today that it was ... Investments reconstituted its comprehensive set of U.S. and ... "This is an important milestone for Pulmatrix," said Chief ... shareholder awareness of our progress in developing drugs for ...
(Date:6/23/2016)... -- MedSource announced today that it has selected Datatrial,s ... choice.  This latest decision demonstrates MedSource,s commitment to ... by offering a state-of-the-art electronic data capture (EDC) ... the EDC platform of choice in exchange for ... long been a preferred EDC platform by our ...
(Date:6/23/2016)... -- Research and Markets has announced the ... (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality (Filler, ... Global Forecast to 2021" report to their offering. ... pharmaceutical excipients market is projected to reach USD 8.1 ... the forecast period 2016 to 2021. ...
Breaking Medicine Technology: